{"title":"Armodafinil","summary":"Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil).[1]  It consists of only the (R)-(âˆ’)-enantiomer of the racemic modafinil. Armodafinil is produced by the pharmaceutical company Cephalon Inc.[2] and was approved by the U.S. Food and Drug Administration (FDA) in June 2007.[3][4] In 2016, the FDA granted Mylan rights for the first generic version of Cephalon's Nuvigil to be marketed in the U.S.[5]","image":"Armodafinil_structure.svg.png.webp","url":"Armodafinil"}